269 related items for PubMed ID: 1808631
1. Predictors of one year outcome in lupus nephritis: the importance of renal biopsy.
Esdaile JM, Federgreen W, Quintal H, Suissa S, Hayslett JP, Kashgarian M.
Q J Med; 1991 Nov; 81(295):907-18. PubMed ID: 1808631
[Abstract] [Full Text] [Related]
2. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature.
Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M.
Q J Med; 1989 Sep; 72(269):779-833. PubMed ID: 2694209
[Abstract] [Full Text] [Related]
3. [Clinical course and prognostic factors in lupus nephropathy].
Gamba G, Quintanilla L, del Bosque MD, Chew-Wong A, Correa-Rotter R.
Rev Invest Clin; 2000 Sep; 52(4):397-405. PubMed ID: 11061101
[Abstract] [Full Text] [Related]
4. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN.
Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
[Abstract] [Full Text] [Related]
5. Clinical usefulness of a prognostic score in histological analysis of renal biopsy in patients with lupus nephritis.
Kojo S, Sada KE, Kobayashi M, Maruyama M, Maeshima Y, Sugiyama H, Makino H.
J Rheumatol; 2009 Oct; 36(10):2218-23. PubMed ID: 19648307
[Abstract] [Full Text] [Related]
6. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K, Yu Y, Tang Z, Liu Z, Li L.
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[Abstract] [Full Text] [Related]
7. Study of lupus nephritis: its classification and the significance of subendothelial deposits.
Tateno S, Kobayashi Y, Shigematsu H, Hiki Y.
Q J Med; 1983 Jul; 52(207):311-31. PubMed ID: 6359226
[Abstract] [Full Text] [Related]
8. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[Abstract] [Full Text] [Related]
9. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.
Faurschou M, Starklint H, Halberg P, Jacobsen S.
J Rheumatol; 2006 Aug; 33(8):1563-9. PubMed ID: 16881113
[Abstract] [Full Text] [Related]
10. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S, Bogić M, Perić-Popadić A, Stefanović L, Arandjelović S, Jovicić Z, Bolpacić J, Tomić-Spirić V.
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[Abstract] [Full Text] [Related]
11. Prognostic factors in diffuse proliferative lupus nephritis.
Abraham MA, Korula A, Jayakrishnan K, John GT, Thomas PP, Jacob CK.
J Assoc Physicians India; 1999 Sep; 47(9):862-5. PubMed ID: 10778652
[Abstract] [Full Text] [Related]
12. Correlation of clinical and pathological findings in patients with lupus nephritis: a five-year experience in Iran.
Nezhad ST, Sepaskhah R.
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):32-40. PubMed ID: 18087120
[Abstract] [Full Text] [Related]
13. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis.
Fraenkel L, MacKenzie T, Joseph L, Kashgarian M, Hayslett JP, Esdaile JM.
J Rheumatol; 1994 Nov; 21(11):2052-7. PubMed ID: 7869309
[Abstract] [Full Text] [Related]
14. The benefit of early treatment with immunosuppressive agents in lupus nephritis.
Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP.
J Rheumatol; 1994 Nov; 21(11):2046-51. PubMed ID: 7869308
[Abstract] [Full Text] [Related]
15. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
[Abstract] [Full Text] [Related]
16. Renal pathology and long-term outcome in childhood SLE.
Sumboonnanonda A, Vongjirad A, Suntornpoch V, Laohapand T, Parichatikanond P.
J Med Assoc Thai; 1998 Nov; 81(11):830-4. PubMed ID: 9803081
[Abstract] [Full Text] [Related]
17. Lupus nephritis: clinical and pathological correlation.
Leaker B, Fairley KF, Dowling J, Kincaid-Smith P.
Q J Med; 1987 Feb; 62(238):163-79. PubMed ID: 3659257
[Abstract] [Full Text] [Related]
18. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.
Gunnarsson I, Sundelin B, Heimbürger M, Forslid J, van Vollenhoven R, Lundberg I, Jacobson SH.
J Rheumatol; 2002 Apr; 29(4):693-9. PubMed ID: 11950009
[Abstract] [Full Text] [Related]
19. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
Magil AB, Ballon HS, Chan V, Lirenman DS, Rae A, Sutton RA.
Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
[Abstract] [Full Text] [Related]
20. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.
Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
